Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/23/2022* -- Results Q2 2023 -- 1.28 --
11/23/2022* 07:00 EST Earnings Call Q2 2023 -- -- --
08/23/2022 -- Results Q1 2023 1.13 1.12 1.02%
08/23/2022 08:00 EST Earnings Call Q1 2023 -- -- --
05/26/2022 -- Results Q4 2022 1.52 1.56 -2.82%
05/26/2022 08:00 EST Earnings Call Q4 2022 -- -- --
02/22/2022 -- Results Q3 2022 1.37 1.37 0.20%
02/22/2022 08:00 EST Earnings Call Q3 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/23/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/23/2022
Beat/Miss Upgrade
Return Since -4.96%
Last FQE 07/31/2022
Next FQE 10/31/2022

Profile

Edit
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
URL https://www.medtronic.com
Investor Relations URL https://investorrelations.medtronic.com
HQ State/Province N/A
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Nov. 23, 2022 (est.)
Last Earnings Release Aug. 23, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 22, 2022

Dividends

Dividend Per Share (TTM) 2.57
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 2.097
Yield to Sector 1.669
Yield to Industry 1.732
Last Dividend Amt. 0.68
Dividend Frequency Quarterly
Last Ex-Dividend Date Sep. 22, 2022
Yield (TTM) 3.10%
Forward Yield 3.20%
Payout Ratio 66.09%
Cash Payout Ratio 60.13%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
8.62%
-5.44%
15.89%
15.19%
27.33%
5.67%
-9.81%
-15.99%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.66%
8.02%
51.35%
-45.80%
-38.32%
-52.55%
12.56%
143.4%
-59.08%
-28.70%
104.2%
56.44%
-16.14%
69.94%
13.41%
32.52%
-20.77%
--
--
--
-61.60%
-79.11%
2.14K%
1.71%
-76.63%
-49.77%
-12.58%
23.10%
35.12%
389.4%
-3.78%
21.81%
-70.32%
As of October 05, 2022.

Profile

Edit
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
URL https://www.medtronic.com
Investor Relations URL https://investorrelations.medtronic.com
HQ State/Province N/A
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Nov. 23, 2022 (est.)
Last Earnings Release Aug. 23, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 22, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
IHI 560.91M USD 9.54%
AEIMX 451.95M USD 4.38%
MOAT 152.32M USD 2.43%
XLV 881.66M USD 2.36%
VDIGX 1.138B USD 2.26%
HDV 257.98M USD 2.23%
VHCIX 397.23M USD 2.14%
VHT 397.23M USD 2.14%
VWNFX 1.054B USD 2.12%
MSDVX 438.72M USD 2.01%
FRDRX 474.03M USD 1.95%
DGRO 230.41M USD 1.07%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter MDT Tweets